Matthew Call

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Call:

Company Role Class Num Shares Value Price $ Report Date Ownership
iTeos Therapeutics, Inc. Chief Operating Officer Common Stock 0 $0 $10.29 29 Aug 2025 Direct
iTeos Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 0 29 Aug 2025 Direct

Insider Reports Filed by Matthew Call

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ITOS iTeos Therapeutics, Inc. 29 Aug 2025 7 $0 4 Chief Operating Officer 29 Aug 2025, 16:30
ITOS iTeos Therapeutics, Inc. 07 Mar 2025 2 $0 4 Chief Operating Officer 11 Mar 2025, 20:00
ITOS iTeos Therapeutics, Inc. 07 Mar 2024 1 $0 4 Chief Operating Officer 08 Mar 2024, 20:00
ITOS iTeos Therapeutics, Inc. 05 Dec 2023 1 $0 4 Chief Operating Officer 07 Dec 2023, 20:22
ITOS iTeos Therapeutics, Inc. 28 Mar 2023 2 +$118,667 4 Chief Operating Officer 29 Mar 2023, 20:00
ITOS iTeos Therapeutics, Inc. 09 Mar 2023 1 $0 4 Chief Operating Officer 10 Mar 2023, 18:52
ITOS iTeos Therapeutics, Inc. 11 Mar 2022 1 $0 4 Chief Operating Officer 14 Mar 2022, 19:58
ITOS iTeos Therapeutics, Inc. 30 Jul 2021 2 +$158,332 4 Chief Operating Officer 05 Aug 2021, 19:55
ITOS iTeos Therapeutics, Inc. 24 Jun 2021 1 $0 4 Chief Operating Officer 25 Jun 2021, 20:00